Impact Partnership Wealth LLC bought a new stake in Cencora, Inc. (NYSE:COR – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 3,723 shares of the company’s stock, valued at approximately $1,170,000.
Other hedge funds also recently bought and sold shares of the company. AustralianSuper Pty Ltd purchased a new stake in shares of Cencora during the 3rd quarter valued at about $26,191,000. Chilton Investment Co. Inc. purchased a new position in Cencora in the third quarter worth about $459,000. Nordea Investment Management AB increased its stake in Cencora by 3.8% during the fourth quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock worth $426,715,000 after acquiring an additional 45,712 shares during the last quarter. Groupama Asset Managment bought a new stake in Cencora during the third quarter worth approximately $1,225,000. Finally, Assetmark Inc. raised its position in Cencora by 57.0% during the fourth quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock valued at $22,724,000 after purchasing an additional 24,431 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.
Analyst Upgrades and Downgrades
COR has been the subject of several analyst reports. Wells Fargo & Company lowered their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. William Blair initiated coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating on the stock. Robert W. Baird lowered their price target on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Finally, Barclays dropped their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research note on Wednesday, June 10th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and a consensus price target of $367.75.
Insider Activity at Cencora
In related news, Director Lauren M. Tyler purchased 550 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the acquisition, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.38% of the company’s stock.
Cencora Trading Up 0.6%
Shares of NYSE COR opened at $283.24 on Wednesday. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The business’s 50 day moving average price is $279.15 and its 200-day moving average price is $321.28. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a market cap of $55.11 billion, a price-to-earnings ratio of 21.72, a PEG ratio of 1.56 and a beta of 0.59.
Cencora (NYSE:COR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.Cencora’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the business posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, sell-side analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current year.
Cencora Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.
Cencora declared that its Board of Directors has approved a share buyback program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.
Cencora Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Featured Stories
- Five stocks we like better than Cencora
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
